GlaxoSmithKline Phar Dividend yield

GlaxoSmithKline Phar is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. GlaxoSmithKline Phar is a company from India, and his stocks are publicly traded.

GlaxoSmithKline Phar stock dividend

GlaxoSmithKline Phar paid a total dividend of 5,411 million INR last year, for a market value of 241,586 millions (Market Cap 60,541 millions). GlaxoSmithKline Phar dividend per share is 32.02 INR, and his stock market price 1,429.50 INR.

According to the chart below, where dividend yield is displayed, GlaxoSmithKline Phar has a dividend yield of 2.24%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.

In addition, you should compare GlaxoSmithKline Phar stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high India dividend stocks list.

GlaxoSmithKline Phar Dividend Payout

About the ability of GlaxoSmithKline Phar to maintain his current dividend of INR 32.02 per share, an amount that accounts for 2.24%, we should study its payout ratio both on earnings and on cash-flows (see chart below). GlaxoSmithKline Phar payout on ernings is currently 87.37%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that GlaxoSmithKline Phar can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of GlaxoSmithKline Phar is INR 32.27 per share, which is higher than the dividend per share paid by the company of INR 32.02, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of GlaxoSmithKline Phar, compared againt world market average, India companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

GlaxoSmithKline Phar Dividend History

Below you will find a table with the historical evolution of GlaxoSmithKline Phar's dividend stock, both in percentage and in INR, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	INR	Paypout	Shares*
Present	2.24%	32.02	87.37%	169
2022	2.27%	29.94	29.74%	169
2015	1.90%	62.63	143.09%	85

*In millions

GlaxoSmithKline Phar Stock performance

Finally, last moth GlaxoSmithKline Phar showed a return of 2.40% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -1.90% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for India and Pharmaceuticals and Biotechnology firms.